Readystate Asset Management »

Apellis Pharmaceuticals shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 25k 58.78

More positions owned by Readystate Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Pfizer Call Option (PFE)
Freshpet Note 3.000% 4/0 (Principal)
Wolfspeed Note 1.875%12/0 (Principal)
Tesla Motors (TSLA)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Eli Lilly & Co. Call Option (LLY)
Intel Corporation (INTC)
Pioneer Natural Resources (PXD)
Hess (HES)
Deere & Company Call Option (DE)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Impinj Note 1.125% 5/1 (Principal)
Alphatec Hldgs Note 0.750% 8/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Jennison Associates
Octagon Capital Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
FMR
Assenagon Asset Management
Boxer Capital
Geode Capital Management
Morgan Stanley

View all funds holding Apellis Pharmaceuticals